Bain Capital Life Sciences Investors, LLC Century Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $557 Million
- Q3 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 5,410,361 shares of IPSC stock, worth $5.41 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
5,410,361
Previous 5,410,361
-0.0%
Holding current value
$5.41 Million
Previous $13.8 Million
32.94%
% of portfolio
1.66%
Previous 2.82%
Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
36.9MCall Options Held
8.7KPut Options Held
10.2K-
Vr Adviser, LLC New York, NY5.39MShares$5.39 Million0.95% of portfolio
-
Boxer Capital, LLC San Diego, CA3.9MShares$3.9 Million0.35% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$3.21 Million0.43% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$2.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.48MShares$2.48 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $58.9M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...